Cochlear Limited revised earnings guidance for the full year 2020. The company reducing the guidance outlook for fiscal year 2020 from $290-300 million, a 9-13% increase on underlying net profit for fiscal year 2019, to $270-290 million, a 2-9% increase on fiscal year 2019 due to an expected impact from the novel coronavirus (2019-nCoV) in Greater China.